EMD-71328

Single-particle
2.92 Å
EMD-71328
3D View Gallery
Deposition: 20/06/2025
Map released: 21/01/2026
Last modified: 29/04/2026
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-71328

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9p6x summary report (pdf.gz) Map-9p6x FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Structure of EBOV glycoprotein in complex with Nanosota-EB1 and EB2

EMD-71328

Single-particle
2.92 Å
EMD-71328
3D View Gallery
Deposition: 20/06/2025
Map released: 21/01/2026
Last modified: 29/04/2026
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Vicugna pacos, Ebola virus - Mayinga, Zaire, 1976, Ebola virus
Sample: EBOV glycoprotein in complex with Nanosota-EB1 and EB2
Fitted models: 9p6x

Deposition Authors: Bu F, Ye G, Li F, Li F
A highly potent and broadly accessible bispecific nanobody for the treatment of ebola virus infections.
Bu F, Ye G, Morsheimer K, Turner-Hubbard H, Eaton B, Anantpadma M, Bheemanapally K, Tan C, Davey R, Li F
(2026) PLoS Pathog , 22 , e1013878 - e1013878
PUBMED: 41592114
DOI: doi:10.1371/journal.ppat.1013878
ISSN: 1553-7374